DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Vaclavik J, Sedlak R, Plachy M et al.
Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.
Hypertension 2011;
57: 1069-1075
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.